Expired
Lead Plaintiff Deadline
Feb 8, 2022
Choose your preferred way to stay informed of new case launches and settlement deadlines
(i) quality control deficiencies existed at the Company’s manufacturing facility for DaxibotulinumtoxinA for Injection ("DAXI"); (ii) the foregoing deficiencies decreased the likelihood that the Food and Drug Administration ("FDA") would approve the DAXI Biologics License Application ("BLA") in its current form; (iii) accordingly, it was unlikely that the DAXI BLA would obtain FDA approval within the timeframe the Company had represented to investors; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
In order to be eligible to join the RVNC class action lawsuit, you must have incurred a loss on shares of Revance purchased during the class period listed above.
If you suffered a loss in Revance during the relevant time frame or pursuant to the relevant offering(s), you have until February 8, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP
